LeapZipBlog: Steve Blade's blog: Drug Discovery Services Market Research Investigates World Market Analysis 2026

Drug Discovery Services Market Research Investigates World Market Analysis 2026

August 20, 2019 by Steve Blade  

 According to a study by Fact.MR, the global market for drug discovery services is likely to experience strong growth. By 2026 end, the global market for drug discovery services is also estimated to bring in US$ 16,800.1 million revenue. Advancements in the drug discovery technologies are leading to the better drug discovery services. Some of the upcoming trends in the market in terms of drug discovery technology are regulatory initiatives towards pharmacogenomics technology, combinatorial chemistry technology, etc. there has also been an increase in the adoption of label-free techniques.

Recently, a partnership accord between US chip maker Intel and Swiss drug-maker Novartis empowered researchers to use ‘deep neural networks’ to cut short the time drastically for assessing microscopic images to 31 minutes from 11 hours. Novartis is not the lone company foraying into AI for drug discovery; British startup Exscientia collaborated with GlaxoSmithKline and followed the suit. The deal will witness discovery of apparently small molecule drugs for up to ten diseases.

Get Free Sample Report Here:  www.factmr.com/connectus/sample?flag=S&rep_id=375

Table of Content

1. Global Economic Outlook

2. Global Drug Discovery Services Market - Executive Summary

3. Global Drug Discovery Services Market Overview
3.1. Introduction
       3.1.1. Global Drug Discovery Services Market Taxonomy
       3.1.2. Global Drug Discovery Services Market Definition
3.2. Global Drug Discovery Services Market Size (US$ Mn) and Forecast, 2012-2026
       3.2.1. Global Drug Discovery Services Market Y-o-Y Growth
3.3. Global Drug Discovery Services Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. PESTL Analysis 
3.7. Product Life Cycle Analysis
3.8. Drug Discovery & Development Process
3.9. Roadmap to Optimize Regulatory and Commercial Success
3.10. Evolution of R&D Drug Discovery Outsourcing
3.11. Service Provider List
3.12. Key Participants Market Presence (Intensity Map) By Region

4. Global Drug Discovery Services Market Analysis and Forecast 2012-2026 
4.1. Global Drug Discovery Services Market Size and Forecast By Process , 2012-2026
       4.1.1. Target Selection Market Size and Forecast, 2012-2026
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Target Validation Market Size and Forecast, 2012-2026
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Hit-To-Lead Identification Market Size and Forecast, 2012-2026

To be Continue................

The British drug giant GSK further inked a research and development pact with Syngene to accelerate the discovery of new drug candidates using the discovery service platforms of the latter.

The stimulus for having machine learning and artificial intelligence in drug discovery is inevitable, as it often cost billions of dollars and takes years to bring a new drug into the market. Besides, Mount Everest-sized pile of drugs succumb to preclinical and clinical testing. Artificial Intelligence and Machine Learning, hence, offer plethora of advantages vis-à-vis traditional methods. Meanwhile, regulatory initiatives towards combinatorial chemistry technology and pharmacogenomics are few of the forthcoming trends in drug discovery services market. 

Medicinal Chemistry to be the Largest Type of Drug Discovery Services

Medicinal chemistry is projected to emerge as the largest type in the drug discovery services market. Medicinal chemistry is estimated to bring in close to US$ 6,100 million revenue. There has been an increase in the outsourcing by pharmaceutical companies, this is emerging as the driving factor. Many drug discovery services providers based in Asia are increasing their foothold in North America and Europe.

A qualitative and quantitative information has been obtained for the forecast and assessment on the drug discovery services market. The research sources include primary and secondary sources which have been further examined by in-house panel of experts. The growth of end use industries in the historical and forecast period have been estimated to aid the readers with their business investment decisions. The market size of the drug discovery services is the result of revenue comparison, market share comparison and Y-o-Y growth comparison on the geography.

Competitive Landscape  

The report also profiles companies that are expected to remain active in the expansion of global drug discovery services market through 2026, which include Syngene, Wuxi Apptec, Aurigene Discovery Technologies, Genscript Biotech Corporation, Covance, Jubilant Biosys, Pharmaceutical Product Development, LLC. (Ppd), Evotec, Charles River Laboratories International, Albany Molecular Research, Inc. (AMRI), GE Healthcare, Merck Millipore, and Thermo Fisher Scientific, Inc.

Have Any Query?? Ask Our Industry Expert 
www.factmr.com/connectus/sample?flag=AE&rep_id=375

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com